In Austria, losing bitcoin to fraud does not count as a taxable loss for private investors because it lacks a formal sale or disposal event. Although the economic loss is real, tax law requires a transaction like a sale to recognize a capital loss. Compensation or repayment received later may trigger taxable events. Business-held cryptocurrencies follow different tax rules. Investors should keep thorough documentation of fraud cases for potential future tax implications if compensation occurs.
The story about Bitcoin and tax rules in Austria is provided here with Pluang's market data for context. For readers following major cryptocurrencies, 33 out of 50 rose and 15 fell today. BAL rose 11.14% to Rp16.297 with a typical hold time of 85 days, CAKE gained 8.82% to Rp41.097 with 69% buy orders and a 75-day hold, and EOS increased 8.13% to Rp12.649 with an 87-day hold, as of Sep 14, 2026 18:51 WIB.
The Royal Canadian Legion has launched its 2026 National Poppy Campaign introducing a new contactless donation method using smartphones, supported by BMO and Toucan Giving technology. This innovation allows volunteers to collect donations via debit, ...
XBiotech Inc. announced the election of Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to leverage their complementary skills and scientific expertise...
XBiotech Inc. announced the appointment of Sushma Shivaswamy and Jan-Paul Simard as co-chief executive officers, effective October 23, 2026. Shivaswamy, with 17 years at the company, has led scientific operations and was interim CEO since December 20...
Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...
Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...
